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Numerous epidemiologic (1-4)  and experimental (5-10)  studies have shown 
that the presence of type-specific antibody induced either by previous infection 
or by artificial immunization with inactivated vaccine is associated with pro- 
tection of subjects against the pathologic consequence of infection with influ- 
enza virus of the same subtype. Other investigations (8-13) have provided evi- 
dence of a less strlk~ng heterotypic protective effect in subjects with antibody 
to one subtype challenged with influenza virus of a different subtype. 
Recent experiments in this laboratory have confirmed the presence of double 
antigenicity in a  plaque purified, stable recombinant virus prepared from A0 
and As virus parents. Mice immunized by infection with this recombinant virus 
have hemagglutination inhibiting antibody only against the A0 virus parent but 
are equally protected against subsequent A0 and As virus challenges as judged 
by reduction in virus replication in the lungs and prevention of lung lesions. 
The broadened immunity induced by infection with this hybrid virus affords 
less protection than the homotypic immunity elicited by prior infection with 
influenza virus of the same subtype as the challenge virus, but is more effective 
in inhibiting viral replication and preventing lung lesions than the slight hetero- 
typic protection observed when mice are immunized by infection with virus of 
one subtype and are challenged with influenza virus of a different subtype (14). 
There is evidence which suggests that one manifestation of immunity to in- 
fluenza virus infection is a decreased likelihood of infection (as shown by anti- 
body rise) in immune subjects compared to nonimmune subjects under similar 
circumstances of exposure (4-7). Nevertheless, infection with a subsequent rise 
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in antibody titer has been clearly and repeatedly shown to occur in individuals 
with preexisting homotypic or heterotypic  antibody  to  the infecting influenza 
virus  (4-7,  15).  Virtually no information  exists,  however, as to whether  these 
partially immune subjects  are as capable  of transmitting  infection as subjects 
lacking specific antibody. 
An experimental model designed to study the transmission  of influenza virus 
infection in mice (16)  was employed in the present  experiments  to investigate 
the effects of varying methods of immunization on transmission of infection. 
Materials and Methods 
M/ce.--Manor Farms  (MF-1) specific pathogen-free male mice 10-16 wk of age were em- 
ployed in all experiments. 
Lungs were removed aseptically at  designated  intervals  and  ground  in  glass  tubes  in 
accordance with techniques previously described (17). 
Viru~es.--The Stuart-Harris neurovirulent strain of WS virus (NWS) was employed as an 
infective strain of influenza .% virus, and the PR8 strain of .% virus was used as formalin- 
inactivated vaccine (400 chick cell agglutinating units/co). An unadapted, inhibitor-sensitive 
strain of virus isolated at the Rockefeller University, N. Y., (RI/5  +) (18) mad mouse adapted 
Jap. 305 virus were used as infective `% viruses. An unadapted strain of Jap. 305 virus (200 
chick cell-agglutinating (CCA)  tmits/ec)  was employed as formalin-inactivated A2 vaccine. 
In most experiments the Lee strain of influenza B virus was also used. 
One other virus employed in most of these experiments is a recombinant virus X-7 derived 
from the NWS strain of .% and the RI/5  + strain of `% virus. This virus has an .%-like hemag- 
glutinating antigen and a  minor `%-like antigen demonstrable by complement  fixation  (CF) 
(19) and plaque size reduction techniques  (19, 20).  At least part and probably all of the `% 
antigen is neuraminidase  (21). 
Demonstration and Titration oJ girus.--The presence of virus in the lungs of animals exposed 
to transmitted infection and the titers of virus in the lungs of infector mice were determined 
by methods previously described (16). 
Hemagglutinating Inhibiting  (HI)  Antibody  Titrations.--HI  antibody  was  titrated  in 
individual mouse sera 4  wk after immunization and  just prior  to A~ virus challenge. The 
mouse-adapted `% (.lap. 305) virus was used as the antigen, and in preliminary tests with this 
virus it was found that trypsin or periodate treatment of serum was not necessary. Sera were 
heated at 56°C for 30 rain and then serial 2-fold dilutions of 0.2 cc of heated serum were made 
in phosphate-buffered saline  (PBS).  A 0.2  cc amount  of the mouse-adapted Jap.  305  virus 
containing  16--32 hemagglutinating units was added  to each tube.  Then,  0.4 cc of human 
"0" red cells were added an after 50 rain at room temperature the tubes  were  observed  for 
the absence or presence of agglutination. 
Searing o] Pulmonary Lesions.--A  modification of the maximal score method  (22) was 
used,  in which the extent of pulmonary lesions  was expressed  as a  percentage of the total 
lung surface. 
Aerosol Procedure.--The apparatus  and technique used to generate an aerosol of infective 
virus has been described elsewhere  (16).  Mice were exposed during a  30 rain  period to an 
estimated 10-100  mouse infective doses  (MID~) of each of the viruses employed. 
Contact Procedure.--I_mmediatdy  after  initiation  of  infection  in  the  aerosol  chamber, 
infector mice were placed in small stainless steel cages,  two mice per cage. 24 hr later  two 
previously uninfected mice were placed in each of the cages.  After a 24 hr period of contact 
the previously uninfected mice were removed and were isolated for 48 hr prior to testing their 
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Immunization Procedurez.--(See  Table I). In all of the present studies,  mice were chal- 
lenged with mouse-adapted A~ (Jap. 305) influenza virus 4 wk after immunization. Challenge 
was presented in the form of either an artificial aerosol of virus or by exposure to infection 
transmitted from other animals infected with the A2 virus. Mice were immunized either with 
homotypic (As) or heterotypic (,%) virus by aerosol infection or by intraperitoneal inoculation 
of formalin-inactivated virus. Control mice were given saline intraperitoneally, or were exposed 
to aerosols  of heterologous influenza B virus or to saline aerosols.  The effects of immunization 
on infector mice were assessed  in terms of pulmonary virus titers and lung lesions  after A2 
TABLE I 
Effect of Various Immunization Procedures on Transmission  of Influenza As Virus 
Infection in Mice--Experimental Design 
InJutor rnic,, 
Immunization 
A2 infection 
A0 infection 
*A2 i.p. 
SA0 i.p. 
X-7 infection 
Challenge 
As aerosol 
As aerosol 
As aerosol 
As aerosol 
A2aerosol 
Infector mice 
Pulmonary 
Virus titers 
(48 hr) 
Lung lesions 
(7 days) 
Measurements 
Contact mice 
Per cent of contacts infected after ex- 
posure  to each infector group 
ConWx$ mic,  e 
Immunization  Challenge  Measurements 
As infection 
Ao infection 
*As i.p. 
~Ao i.p. 
X-7 infection 
Exposure to infector mice in- 
fected with A2 virus 
Per cent of each contact group infected 
after contact exposure 
* Formalin-inactivated Jap. 305 virus 200 CCA units/cc. 
:~ Formalin-inactivated PR8 virus 400 CCA units/cc. 
challenge, and by their ability to transmit infection to exposed contacts. In contact animals 
the effect of immunization was judged simply by the proportion of each contact group which 
acquired transmitted infection. 
~X~xRI~ENTAL RESULTS 
E~ect of Immunity Induced by Prior In/ection.--Mice  were infected by ex- 
posure to aerosols of A~, A0, or recombinant X-7 (AoA2) virus. Control mice were 
infected with influenza B  virus or were exposed to saline aerosols. 4 wk later the 
animals  were challenged by exposure  to  an  aerosol of  influenza A~ (Jap.  305) 
virus. Pulmonary virus was titrated 48 hr later and lung lesions were assessed 7 470  TRANSMISSION  OF  INFLUENZA  VIRUS  INFECTION.  III 
days after infection. The results are shown in Table II. Mice immunized 4 wk 
previously by homotypic influenza A~ virus infection were competely refractory 
to reinfection. None had demonstrable pulmonary virus 48 hr after challenge. 
Mice  immunized  by infection  with  the  heterotypic  influenza  A0  virus  were 
partially protected as shown by lower pulmonary virus titers and less extensive 
lung  lesions  than  control  mice.  Immunization by infection  with  the  recom- 
binant X-7 virus was more effective than immunization  by infection with the 
A0 parent, and resulted in even lower pulmonary virus titers and less extensive 
lung lesions,  but the protection afforded was not  as great as that induced by 
the  As  virus  parent  (homotypic  to  the  challenge).  Prior  infection  with  the 
heterologous  influenza  B  virus  provided  no  protection  against  the  A2  virus 
challenge. 
TABLE II 
Effect of Previous Infection  of Mice with Homotypic or Heterotypic  Virus on 
Subsequent Challenge with Influenza A2 Virus 
Initial infection  *HI antibody to  *Challenge  ~;Pulmonary virus  As virus  infection  titers (48 hr)  Lesions (7 days) 
Saline 
B  (Lee) 
Ao (NWS) 
AoA~ 
As (RI/5  +) 
<1:8 
<1:8 
<1.8 
<1.8 
1:32 
A2 
A2 
A~ 
A~ 
A2 
7.7 
7.7 
6.5 
5.5 
<1.0 
% 
61.3 
62.5 
30 
9.6 
0 
* 4 wk following initial infection. 
Log10, EID~o,  mean of individual titers, five  animals in each group. 
The effects of these differing immunization procedures on transmission of in- 
fection were studied in cohort mice immunized at the same time. Some animals 
were challenged by exposure to an artificial aerosol of As virus and were  em- 
ployed as infectors with normal contact mice. Others were placed in contact with 
unintmunized infector mice infected 24 hr earlier with influenza  A2 virus. The 
summarized results of eight experiments are presented in Table III. The upper 
part of the table indicates the results when immunized mice,  challenged with 
A2 virus were used as infectors; the lower part of the table indicates  the results 
when immunized mice were used as contacts with unimmunized A2 infectors. 
Mice immunized by prior homotypic influenza A2 virus infection were not rein- 
fected when challenged and did not transmit infection. Similarly as shown in the 
lower half of the table, they were completely refractory to infection transmitted 
by "control" (previously unimmunized) infectors. Infector mice immunized by 
prior infection with influenza A0 virus or with the X-7 virus transmitted infec- 
tion less frequently than control infectors, and contact mice immunized 4  wk JEROME L.  SCHULM.AN  471 
earlier by infection with these viruses  acquired  transmitted infection less fre- 
quently than control contacts. In each case the effect was more pronounced in 
mice immunized with the recombinant (X-7) virus. Thus with the experimental 
conditions employed, mice infected with A2 (RI/5  +) virus were completely re- 
fractory to reinfection when challenged either by exposure to an aerosol of A~ 
virus or by exposure to A~ virus infection transmitted by other mice. The partial 
protection afforded by prior infection with influenza A0 virus or recombinant 
(AoA2) virus is associated with decreased transmission during their infection to 
A~ virus and with diminished susceptibility to A2 virus infection transmitted by 
other mice. 
TABLE III 
Effect of Previous Infection of Mice with HomotyOi~, Heterotypie,  or Heterologous 
Virus on Transmission of Influenza As Virus Infection 
Previous influenza virus infection 
Infector* group 
Saline 
B (Lee) 
Ao (NWS) 
AoA2 (X-7) 
As (RI/5  +) 
None 
None 
None 
None 
None 
Contact group 
None 
None 
None 
None 
None 
S~Lline 
B (Lee) 
A0  (NWS) 
AoAs  (X-7) 
As (RI/5  +) 
Contacts infected 
% 
81/162  (50.0) 
57/161  (35.4)~ 
15/145  (lo.5) 
9/96  (9.4) 
0/4o  (o) 
37/75  (49.3) 
26/64  (4O.6):I 
13/49  (26.5) 
(7/53)  (13.2) 
(o14o)  (o) 
* Aerosol infection 4 wk prior to A2 virus challenge. 
_p >  0.05. 
Effect of Immunization with Inactivated A2 Virus.--Mice were immunized by a 
single intraperitoneal injection of 0.2 cc of a 1: 5 dilution of formalin-inactivated 
A2 (Jap. 305) virus containing 200 CCA units/ce. Control mice were given saline 
intraperitoneally. 4 wk later some mice from each group were bled and their 
sera tested for HI antibody against A2 (Jap. 305) virus.  The remaining mice 
were challenged with A2 (Jap. 305) virus and pulmonary virus titers were meas- 
ured 48 hr later and lung lesions were assessed 7 days later. The results as seen 
in Table IV simply indicate that mice immunized with inactivated A2 vaccine 
in this dosage have HI antibody at the time of A2 virus challenge and have lower 
pulmonary virus titers and less extensive lesions following challenge. It should 
be noted that HI antibody titers following intraperitoneal injection of inacti- 472  TRANSMISSION  O~"  INFLUENZA  VIRUS  INFECTION.  IlI 
vated A, vaccine were equivalent to those induced by prior A~ virus infection 
(Table II). The effects on transmitted infection induced by immunization with 
inactivated homotypic (A2) virus were studied as follows: mice were inoculated 
intraperitoneally with inactivated A2 virus or with saline. 4 wk later some mice 
TABLE IV 
Effect oJ Prior Inoculation  with Inactivated  A~ Virus Vaccine on Subsequent As 
Virus Challenge 
.......  Immunization .............................  AA t i.p. 
HI antibody to A~ virus* ....................  [  1:32 
Challenge* ................................  [  As (aerosol) 
Pulmonary virus titers (48 hr) * ..............  [  5.7 
Lung lesions (7 days) %  ....................  [  2.5 
Saline i.p. 
<1:8 
A2 (aerosol) 
7.7 
62 
A 0.2 cc of a 1:5 dilution of formalin-inactivated  Jap. 305 virus 200 CCA units/cc. 
* 4 wk after immunization. 
EID60, logx0,  individual titers of five animals in each group. 
TABLE V 
Effect of Inactivated  Bomotypic  Vaccine on the Transmission of Influenza  Virus 
Infection in Mice 
Infector mice 
Immunized* 
Unimmunized 
Contact mice 
No. infected/total No. in group 
Immunized  Unimmunized  Total 
6/32 
(18.7%) 
2/31 
(6.4%) 
30/60 
(50%) 
29/61 
(47.5%) 
Total ....................  8/63  59/121 
(12.7%)  (48.8%) 
36/92 
(39.1%) 
31/92 
(33.7%) 
* 0.2 cc of a 1: 5 dilution of formalin-inactivated A~ virus, intraperitoneally 4 wk before 
challenge. 
from each group were infected with A~ virus and were used as infectors, while 
the remaining animals were employed as contacts. 
Four different contact situations thus were established: immunized infectors 
and  immunized  contacts;  immunized  infectors  and  unimmunized  contacts; 
unlmmunized  infectors and  immunized contacts; and  unimmunized  infectors 
and unlmmunized contacts. The proportion of contacts infected in each contact 
situation can be seen in Table V. Immunized contacts acquired transmitted in- JEROME  L.  SCHULMAN  473 
fection far less frequently than un~mmunized contacts. However, immunized 
infectors  transmitted  infection  just  as  readily  (39.1%)  as  tmimmunized 
infectors  (33.7%).  Therefore,  although immunized infectors had lower pul- 
monary virus titers following A~ virus challenge than unlmmunized infectors, 
their ability to transmit infection was not affected. 
Effect of Inactivated Heterotypic (A o) Vaccine.--Mice inoculated weekly for 3 
wk with saline or with 0.2 cc of a  1:5 dilution of formalin-inactivated A0 virus 
(400 CCA units/cc) were challenged with A2 virus 1 wk after the last injection 
and were used as infectors, or were not challenged and were used as contacts. 
The results can be seen in Table VI. Inactivated A0 virus given intraperitoneally 
did not result in lower pulmonary virus titers following A, challenge and in- 
fectors immunized in this way were as capable of transmitting A~ virus infec- 
TABLE  VI 
Effect of Parenteral Immunization with Inactivated Influenza A o Virus on 
Pulmonary Virus Tilers and Transmission  of Infection Following 
Influenza A~ Virus Challenge 
Infector mice  Contact mice/No, infected 
Pulmonary virus  Immunization  titers (48 hr)*  Saline  AA0  Total 
Saline  7.5  6/10  4/10  10/20 
A Ao  7.6  5/10  3/10  8/20 
Total .............  11/20  7/20 
A  3 intmperitoneal injections at weekly intervals 0.2 cc of a  1:5 dilution of formalin-in- 
activated PR8 virus 400 CCA units/cc. 
* Logx0 EIDs0 five animals in each group. 
tion as unimmunized infectors. Similarly, contact mice immunized with inacti- 
vated A0 virus  were  just as susceptible to transmitted A, virus infection as 
unimmunized contacts. Therefore, inactivated A0 virus vaccine given at a  pe- 
ripheral site did not protect mice against As  virus challenge and did not in- 
fluence either the ability of immunized infectors to transmit  infection or the 
susceptibility of immunized contacts to transmitted infection. 
DISCUSSION 
The definitive expression of antiviral immunity is the capacity of the host to 
inhibit multiplication of the invading virus and consequently to inhibit virus- 
induced lesions, but an alternative expression is the ability of the host to resist 
the initiation of infection under circumstances of exposure in which infection is 
likely. From an epidemiologic standpoint, still another consideration assumes 
importance -- the capacity of a partially immune (but infectable) host to trans- 474  TRANSMISSION  OF  INFLUENZA  VIRUS  INFECTION.  III 
mit infection to others. In the present experiments, immunity induced to in- 
fluenza A2 virus by different immunization procedures was assessed in three 
ways: (a) in terms of its protective effect in mice directly challenged with aero- 
sols of influenza A2 virus; (b) by its effect on susceptibility to initiation of mouse- 
to-mouse transmitted  infection; and  (c)  by its  effect on the capacity of im- 
munized infector mice to shed virus and to transmit infection to other mice. The 
effects of the different immunization procedures as reflected by these three in- 
dications of altered host susceptibility are summarized in Table VII. All of the 
changes observed are believed to have been mediated through specific immuno- 
logic mechanisms. Viral interference has been excluded as a factor because of 
the duration of altered host susceptibility and because of the absence of any 
effect following heterologous influenza B virus infection (17). 
TABLE VII 
Summary of E.ffects of Differing Immunization Procedures on Response to 
Challenge Injection, Susceptibility to Transmitted Infection, and the 
Capacity to Transmit Influenza A~ Virus Infection 
Immunization 
A~ infection 
A2 vaccine* 
A0 infection 
AoA2 (X-7) infection 
A0 vaccine 
B infection 
Virus titers and 
lesions  following 
aerosol 
challenge 
No infection 
Reduced 
Reduced 
Reduced 
No effect 
No effect 
Resistance to 
iTion~e-to-nlouse 
transmitted 
infection 
Complete 
Increased 
Increased 
Increased 
No effect 
No effect 
Caimcity to 
transmit 
challenge 
infection 
No transmission 
No effect 
Decreased transmission 
Decreased transmission 
No effect 
No effect 
* Intraperitoneal injection of noninfective  virus. 
With the exception of prior parenteral inoculation of inactivated heterotypic 
influenza A0 virus all of the immunization procedures utilizing Type A influenza 
viruses resulted in at least partial protection of mice challenged by exposure to 
nebulized influenza A2 virus. This protection was reflected by a  reduction in 
pulmonary titers of challenge virus and by diminished lung lesions. The most 
potent immunization procedure was prior infection with homotypic influenza 
As virus. Mice immunized in this way were not reinfected when challenged with 
as much as 1000 MIDs0 of aerosolized virus. This refractoriness to aerosol chal- 
lenge has been found in other experiments in this laboratory to persist for at 
least 1 yr. In contrast, mice immunized with a single intraperitoneal injection of 
inactivated  (noninfective) influenza A2 virus were uniformly infected when chal- 
lenged by exposure to an aerosol of 100 MIDs0 of As virus. The decreased pro- 
tection afforded by inactivated homotypic vaccine cannot be explained on the JEROME  L.  SCHULMAN  475 
basis of inadequate antibody response as the serum titers of hemagglutinating- 
inhibiting antibody in the completely resistant mice immunized by homotypic 
infection and in mice immunized by inactivated homotypic vaccine were identi- 
cal. The data, therefore, suggest that local immunologic mechanisms are opera- 
tive. Francis (23), and Fazekas de St. Groth (24) have shown that the extent 
to which mice are protected against influenza  virus challenge  is more closely 
correlated with titers of antibody in respiratory tract secretions than with titers 
of humoral antibody. It is thought that the local antibody is derived from hu- 
moral antibody which diffuses  into  the respiratory tract  secretions from the 
blood stream, but an alternative hypothesis is that the antibody is produced 
directly by cells within or adjacent to the respiratory tract. A similar mechanism 
has been postulated to explain the resistance to gastrointestinal reinfection ob- 
served in subjects immunized with live attenuated poliovirns that is not ob- 
served in subjects immunized with inactivated poliovirus vaccine (25). Recent 
studies have shown  that  the  immunologically specific inhibitory activity of 
respiratory tract secretions resides predominantly in the ~A-globulin fraction of 
the proteins recovered whereas the "yG-globulin fraction contains most of the 
serum activity. It may be that infection provides a more potent stimulus to the 
formation and/or the release of ~A-globulin in respiratory tract secretions (26- 
28). 
Additional evidence that protection is not due to preexisting humoral anti- 
body alone is provided by the observation that mice immunized by infection 
with the heterotypic influenza A0 or AoAs viruses (although lacking detectable 
serum influenza  As antibody) were partially immune.  Following  influenza  A~ 
virus challenge  by aerosol these mice had lower pulmonary virus titers and less 
extensive lung lesions than control animals. 
The effects of the different immunization procedures on the likelihood of im- 
munized contact mice acquiring transmitted infection were exactly parallel to 
resistance to aerosol challenge with influenza  As virus.  All of the immunization 
procedures employed, with the exception of inactivated heterotypic A0 virus 
vaccine, resulted in resistance of mice to mouse-to-mouse transmitted infection. 
Mice immunized by A~ infection that were refractory to reinfection by nebulized 
aerosol challenge  were also completely refractory to A2 virus infection trans- 
mitted by other mice, whereas 12.7  % of contacts immunized with inactivated 
As virus vaccine acquired transmitted infection when exposed to infected cage 
mates.  Similarly,  immunization  by prior  infection  with  A0 or  AoAs viruses 
(associated with increased resistance to nebulized As virus challenge)  resulted 
also in an increased resistance to the likelihood  of acquisition of mouse trans- 
mitted infection. 
With respect to the effect of these immunization procedures on the capacity 
of infector mice to transmit infection, locally expressed immunologically specific 
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to A2 virus reinfection  in mice immunized  by prior  homotypic (A2) infection 
renders them incapable of transmitting infection. In contrast, mice immunized 
by parenteral injection of inactivated homotypic A2 virus vaccine could be rein- 
fected by exposure to aerosols of nebulized virus and were fully capable there- 
after of transmitting infection to other mice. This unimpaired transmission  is 
dflficult to explain in that mice immunized in this way had lower titers of pul- 
monary virus than control infectors  and presumably had less virus available 
to be shed into the environment.  It may be that the virus which is shed during 
transmission is derived from the most superficial portions of the respiratory ep- 
ithelium where it is less vulnerable  to inactivation by serum antibody. Con- 
versely,  mice  partially immunized by  prior  infection  with  the  heterotypic 
influenza A0 or recombinant AoA2 viruses transmitted infection less well follow- 
ing their infection with A~ virus, although peak pulmonary virus titers were as 
high or higher than in animals  immunized with inactivated As virus vaccine. 
The  immunological  specificity of these effects on the transmission  of infection 
to other mice is suggested by the observation  that transmission  of A2 virus in- 
fection is not altered in mice previously infected with the  antigenically un- 
related  influenza  B  virus.  It may be  that  these  local immunologic  mecha- 
nisms  affect  the availability of  unbound infectious  virus  for expulsion  into 
the environment. 
The superiority of infection-induced immunity both in its effect on suscepti- 
bility to challenge and in its effect on the shedding of virus and the subsequent 
spread of infection may have important epidemiologic implications.  Similarly, 
the broadened immunity induced  by infection with a  hybrid influenza virus 
possessing antigenic components of both parents has potential value as an im- 
munization procedure. 
SLrM~ARY 
Immunization of mice by infection or intraperitoneal injection with homo- 
typic A~, heterotypic Ao, or recombinant AoA2 virus have differing effects on 
transmission of influenza As virus infection. Immunization by infection with A9 
virus resulted in refractoriness  to reinfection either by artificial aerosols or by 
exposure to infected cage-mates. Immunization by inoculation with inactivated 
A, virus vaccine resulted in a decreased susceptibility to transmitted infection 
in immunized  contacts, but following A~ virus challenge,  transmission  of in- 
fection by immunized infectors was not altered. Immunization by infection with 
influenza Ao virus or recombinant AoAs virus resulted  in a decreased suscepti- 
bility to transmitted A2 virus infection in immunized contacts, and to decreased 
transmission after A2 virus infection in immunized infector mice. These differing 
effects on transmission of infection are attributed to differences in specific local 
immunologic responses following the various immunization procedures. JEROME  L.  SCHULMAN  477 
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